CFTR and cystic fibrosis: The first example of nonsense suppression therapy was provided by using the aminoglycoside G418 (geneticin) (Figure 2), in cultured cells harboring nonsense mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), whose dysfunction in humans causes the relevant genetic inherited disease (CF) [46].